Nie, Y., Ding, Y., & Yang, M. (2020). GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin. Onco Targets Ther.
Styl ChicagoNie, Yanting, Yiling Ding, a Mengyuan Yang. "GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin." Onco Targets Ther 2020.
Citace podle MLANie, Yanting, Yiling Ding, a Mengyuan Yang. "GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin." Onco Targets Ther 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..